Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |